Bogus HIV tests
This article was originally published in The Gray Sheet
Federal Trade Commission settles charges against Medford, New York-based Chembio Diagnostic Systems and San Diego-based Alfa Scientific Designs alleging the firms made false claims about the accuracy of unapproved rapid HIV antibody tests. The settlement bars the firms from making or assisting others in making false or misleading representations concerning the accuracy of any unapproved HIV test or other unapproved device. Over the past two years FTC has settled similar charges against distributors of both the Chembio and Alfa tests; however, the latest action is the first brought against manufacturers of such tests
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.